|
JAK generic sales stood at over Rs 3,500 crore from FY20 to first quarter of FY24
|
|
Gireesh Babu, New Delhi
August 31 , 2024
|
|
|
The generic medicine sales through the Jan Aushadhi Kendras (JAKs) under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) for the last five financial years including the first three months of the current financial year has been at Rs 3,548.79 crore.
This is almost 63 per cent of the total sales made through these stores from the commencement of the JAK scheme in 2008.
According to the data from the ministry of chemicals and fertilisers, the total sales of Jan Aushadhi generic medicines in the first three months of the fiscal year 2024-25, till June, 2024, is Rs 437.94 crore. In 2023-24, the total sales of JAKs were at Rs 907 crore, as compared to Rs 799.09 crore in 2022-23, Rs 645.72 crore in 2021-22, Rs 445.46 in 2020-21, and Rs 313.59 crore in 2019-20.
The data submitted by the Ministry in Lok Sabha in the recent session also shows that Kerala reported the highest sales through JAKs in the period from 2019-20 to the first quarter of 2024-25, at Rs 630.96 crore, followed by Karnataka with Rs 563.95 crore sales, Uttar Pradesh with Rs 524.51 crore sales, Tamil Nadu with Rs 307.99 crore sales, and West Bengal with Rs 228.24 crore sales.
Among the states, Chhattisgarh has shown a remarkable improvement in generic drug sales through JAKs, from Rs 4.47 crore in 2021-22, Rs 5.54 crore in 2022-23, Rs 6.56 crore in 2023-24, to Rs 34.17 crore in the first three months of 2024-25.
JAK's sales in States such as Goa, Arunachal Pradesh, Sikkim, and Union Territories such as Andaman and Nicobar Islands, Lakshadweep, Dadra and Nagar Haveli and Daman & Diu are the least compared to other parts of the country. In Lakshadweep, the medicines are directly supplied to the administration of the Union Territory, says the Ministry.
The government has set a target of opening 25,000 JAKs across the country by March 31, 2027, after achieving a target of 10,000 JAKs before the target timeline set by it earlier.
"In the last 5 years there is substantial increase in the product basket of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) which presently comprises of 2047 medicines, and 300 surgical and medical consumables," said Anupriya Patel, the minister of state in the ministry of chemicals and fertilisers recently in the Lok Sabha.
These medicines cover all therapeutic groups such as analgesic & antipyretic/anti-inflammatory, antidiabetic, anti-biotic and anti-fungal, cardiovascular, psychotropic, dermatology, vitamins & minerals, gastrointestinal, respiratory, anti-cancer, etc., she added.
"Over the last 10 years, sale of medicines worth Rs 5,600 crore have been made through PMBJKs, which has led to estimated savings of Rs 30,000 crore to the citizens. Further, the scheme provides opportunities for self-employment with sustainable and regular earnings," she said on July 26, 2024 in the Lok Sabha.
Over the last 10 years, there has been a 200 times increase in sales turnover. It increased from Rs 7.29 crore in 2014 to Rs 1,470 crore till June 30, 2024, she said in another instance during the recent Parliament session.
Under PMBJP, 5 ayurvedic products have been added in the product basket, which are available at affordable rates. The products are Chyawanprash Special 500 gm, Chyawanprash Special 1000 gm, Triphala, Shilajit and Ashwagandha.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|